
南美洲和中美洲哮喘药物市场预测至 2028 年 - COVID-19 影响和药物(快速缓解药物和长期控制药物)、给药途径(吸入、预充注射器/小瓶等)和分销渠道的区域分析(网上药房、医院药房和零售药房)
No. of Pages: 143 | Report Code: BMIRE00025222 | Category: Life Sciences
No. of Pages: 143 | Report Code: BMIRE00025222 | Category: Life Sciences
市场的增长是由于哮喘患病率的上升,以及不断增加的研究活动和产品创新正在推动哮喘药物市场的增长。然而,未满足的医疗需求正在阻碍市场增长。
哮喘是一种慢性呼吸道疾病,其特征是气流受限波动、支气管高反应性和气道损伤炎。根据题为“空气污染对哮喘结果的影响”的评论论文, Tiotiu 等人指出,空气污染阻碍了成人和儿童的哮喘结局。交通造成的空气污染、二氧化氮 (NO2) 和二手烟 (SHS) 都是儿童患哮喘的重要危险因素。接触外部污染可能会引发哮喘症状、病情加重和肺功能下降。
一项由环境保护局资助的新研究( EPA)分析了空气污染与哮喘之间的联系。虽然由于空气污染,专家无法确定导致哮喘的主要因素,但有证据表明,空气污染会抑制控制免疫系统区分过敏原和有害异物(例如病毒或细菌)的基因。然后,免疫系统就会过度运转,无论药物是否有毒,都会引发炎症反应,从而导致哮喘。
斯坦福大学的研究人员儿童中心调查了空气污染对来自高污染地区儿童的两种与免疫耐受性有关的基因的影响。他们发现,短期和长期接触大量一氧化碳 (CO)、NO2 和 PM2.5(颗粒物)与这两个基因的变化有关,从而导致哮喘。这些发现重点关注空气污染暴露对表观遗传的影响,可能有助于开发预防性哮喘药物。
这些哮喘研究中的每一项都具有提高了对儿童哮喘的了解,并向 EPA 提供了可用于保护人类健康和环境的重要信息。通过这些研究工作,哮喘药物的发现和开发正在加速,从而推动哮喘药物市场的发展。
< /strong>
南美洲和中美洲哮喘药品市场细分
南美洲和中美洲哮喘药物市场按药物划分,分为快速缓解药物和长期控制药物。根据给药途径,南美洲和中美洲哮喘药物市场分为吸入型、预充注射器/小瓶型等。 根据分销渠道,南美洲和中美洲哮喘药物市场分为在线药房、医院药房、零售药店和药店从地理上看,南美洲和中美洲哮喘药物市场分为巴西、阿根廷以及中南部和中美洲其他地区美国。
阿斯利康、梯瓦制药工业有限公司、
勃林格殷格翰国际有限公司、葛兰素史克公司、默克公司Co., Inc.、Koninklijke Philips NV、赛诺菲、
辉瑞公司 (Arena Pharmaceutical GmbH)、诺华公司 (Novartis AG) 和雅培 (Abbott) 都是在南部和中部地区运营的领先公司美国哮喘药物市场。
Strategic insights for South and Central America Asthma Drugs involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1,863.99 Million |
Market Size by 2028 | US$ 2,672.86 Million |
Global CAGR (2021 - 2028) | 5.3% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 药物治疗
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South and Central America Asthma Drugs refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America Asthma Drugs Market is valued at US$ 1,863.99 Million in 2021, it is projected to reach US$ 2,672.86 Million by 2028.
As per our report South and Central America Asthma Drugs Market, the market size is valued at US$ 1,863.99 Million in 2021, projecting it to reach US$ 2,672.86 Million by 2028. This translates to a CAGR of approximately 5.3% during the forecast period.
The South and Central America Asthma Drugs Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Asthma Drugs Market report:
The South and Central America Asthma Drugs Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Asthma Drugs Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Asthma Drugs Market value chain can benefit from the information contained in a comprehensive market report.